Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

Non-LTR Retrotransposons

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Lung cancer care pathways and journeys: insights from patients at the National Cancer Institute in Mexico.

BMC global and public health·2026

Same author

Orbital Exenteration for Primary Tumors or Secondary to Extension Among Hospital Patients: A Retrospective Case Study.

Journal of maxillofacial and oral surgery·2026

Same author

Reply to the letter regarding "preoperative prognostic nutritional index in prediction of surgical complications and oncological outcomes in retroperitoneal sarcoma".

Updates in surgery·2026

Same author

Predicting Early Metastasis in Extremity and Trunk Sarcomas: A Retrospective Analysis of 344 Patients.

Oncology·2026

Same author

The importance of surgery at an oncologic institution as a prognostic factor in patients with endometrial carcinoma.

Surgical oncology·2026

Same author

Peritoneal Sarcomatosis Secondary to Conventional Chondrosarcoma: A Case Report.

Cureus·2026

Same journal

A new paradigm for esophageal disease management: the application and future prospects of Shared Decision Making (SDM).

World journal of surgical oncology·2026

Same journal

Retrospective analysis of the occurrence pattern of complications and prognostic influencing factors in elderly patients with squamous cell lung cancer after radical surgery.

World journal of surgical oncology·2026

Same journal

Prognostic value of the immune-inflammatory indices in osteosarcoma: a systematic review and meta-analysis.

World journal of surgical oncology·2026

Same journal

Prognostic impact of lymph node ratio after suboptimal lymphadenectomy in gastric cancer: a retrospective cohort study with interaction analysis.

World journal of surgical oncology·2026

Same journal

Risk-adapted nodal evaluation in stage IA non-small cell lung cancer: a population-based competing-risk analysis.

World journal of surgical oncology·2026

Same journal

Oncologic outcomes after poly-4-hydroxybutyrate scaffold in post-mastectomy breast reconstruction: a retrospective, multi-center cohort study.

World journal of surgical oncology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 28, 2026

Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer

Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer

Published on: October 31, 2025

Giant retroperitoneal liposarcoma.

Angel Herrera-Gómez¹, César Ortega-Gutiérrez, Alejandro Mohar Betancourt

¹Department of Surgical Oncology, Instituto Nacional de Cancerología, México, D.F., Mexico.

World Journal of Surgical Oncology

|November 4, 2008

Summary

This summary is machine-generated.

Giant retroperitoneal liposarcoma treatment can be challenging. Surgical intervention, even after palliative chemotherapy failure, may lead to successful outcomes and prolonged disease-free survival in select cases.

Related Experiment Videos

Last Updated: Jun 28, 2026

Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer

Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer

Published on: October 31, 2025

Area of Science:

Oncology
Surgical Oncology
Soft Tissue Sarcomas

Background:

Retroperitoneal liposarcoma is the most common soft tissue sarcoma in this anatomical location.
Complete surgical resection is the established gold standard for treating liposarcoma.
Management of unresectable or recurrent retroperitoneal liposarcomas presents significant challenges.

Observation:

A case of a 24-year-old male with a giant retroperitoneal liposarcoma is presented.
The patient initially received palliative chemotherapy due to non-resectable tumor status.
Systemic treatment provided no demonstrable benefit, prompting a reassessment of surgical options.

Findings:

Complete macroscopic tumor resection was achieved without the need for multi-organ resection.
The patient remains alive and disease-free at 14 months post-operatively.
This case highlights the potential for surgical success even after neoadjuvant chemotherapy failure.

Implications:

Aggressive surgical approaches, including re-exploration for recurrences, may be necessary for retroperitoneal liposarcomas.
Surgical resectability should be evaluated based on individual patient tolerance and potential for symptom palliation.
Careful consideration of the balance between surgical morbidity and the likelihood of achieving prolonged survival is crucial.